by | Jan 23, 2026 | Lupus Foundation of America
Top Takeaways from the Webinar:Â Advocating for yourself starts with respect for both yourself and your care team. By recognizing that you deserve attentive, supportive care, you can confidently communicate your needs to ensure your voice is heard.You are the expert on...
by Lupus Foundation, Ohio | Jan 15, 2026 | Lupus Foundation of America, News & Events
In a  new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen autoimmune skin conditions, such as in people with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE). They identified 227...
by Lupus Foundation, Ohio | Jan 11, 2026 | Lupus Foundation of America, News & Events
AstraZeneca reported positive results from a Phase III TULIP-SC clinical trial, showing a statistically significant and clinically meaningful reduction in disease activity with the subcutaneous (SC), self-administration of Saphnelo (anifrolumab) in adults with...
by Lupus Foundation, Ohio | Jan 9, 2026 | Lupus Foundation of America, News & Events
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug therapy, nipocalimab, met its primary endpoint and multiple key secondary and exploratory endpoints in adults with systemic lupus...
by | Jan 5, 2026 | Lupus Foundation of America
For people living with lupus, pain can be one of the most persistent and difficult symptoms to manage. Whether it’s joint discomfort, muscle aches or nerve-related pain, lupus symptoms can make daily activities feel overwhelming. But the good news is that a...
by | Dec 18, 2025 | Lupus Foundation of America, News & Events
A new study finds that experiences of discrimination are associated with worse patient-reported lupus-related symptoms and depressive symptoms among people with systemic lupus erythematosus (SLE). Patient-reported disease activity such as pain, fatigue and depression...
